Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial.
Vaccine
; 41(13): 2137-2146, 2023 03 24.
Article
in En
| MEDLINE
| ID: mdl-36828719
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pneumococcal Infections
/
Influenza Vaccines
/
Influenza, Human
Type of study:
Clinical_trials
Limits:
Aged
/
Humans
Language:
En
Journal:
Vaccine
Year:
2023
Document type:
Article
Country of publication: